Mar 11, 2014 at 09:35 | Source: Moneycontrol.com
According to Way2Wealth.com, on lower side aggressive put writing has been seen around 6400 levels and that will continue to be strong support for indices whereas 6580-6620 will act as stiff resistance.
Mar 10, 2014 at 14:20 | Source: CNBC-TV18
Havells India is the only capital goods stock which is near all time high of Rs 844-845 and once that level breaks, a big move upside is possible. The stock is likely to outperform every capital goods stocks, says Independent Advisor, AK Prabharkar.
Mar 10, 2014 at 09:07 | Source: CNBC-TV18
Pankaj Jain of Sunteck Wealthmax advises buying HDIL for a target price of Rs 51.95 and HOEC for a target price of Rs 47.95.
Mar 07, 2014 at 15:27 | Source: CNBC-TV18
Biocon CMD Kiran Mazumdar-Shaw said the companys research efforts are focused on a number of programs that deliver drugs that women can benefit from.
Mar 07, 2014 at 14:59 | Source: CNBC-TV18
Sharmila Joshi of sharmilajoshi.com is of the view that one may avoid Ranbaxy Laboratories and prefer Biocon, Ipca Laboratories and Cipla from the pharmaceutical space.
Mar 06, 2014 at 13:33 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Divis Laboratories.
Mar 05, 2014 at 21:52 | Source: CNBC-TV18
Launching a new drug in India, whether a completely new molecule or a generic one, has become a herculean task. The Supreme Court's recent dictat that the government review 157 clinical trials has delayed fresh approvals.
Mar 05, 2014 at 09:58 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Elder Pharmaceuticals, Lupin, Sun Pharmaceutical Industries, Cipla, Biocon and Aurobindo Pharma will get astrological support.
Mar 04, 2014 at 11:26 | Source: Moneycontrol.com
Pharma stocks like Indoco Remedies, Lupin, Sun Pharma, Cipla, Biocon, Aurobindo Pharma and Panacea Biotec will be getting astrological support, Satish Gupta of Astrostocktips said.
Mar 03, 2014 at 15:22 | Source: Moneycontrol.com
Systematix Shares has recommended traders to buy Biocon, Andhra Bank for the target price of Rs 467 and Rs 58 respectively in its research report dated March 03, 2014.